Cervical Cancer Screening With Both Human Papillomavirus and Papanicolaou Testing vs Papanicolaou Testing Alone
نویسندگان
چکیده
منابع مشابه
Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
BACKGROUND Guidelines recommend screening for cervical cancer among women 30 years or older 3 years after a normal Papanicolaou test (hereinafter referred to as Pap test) result or a combined normal screening result (normal Pap/negative human papillomavirus [HPV] test results). We assessed reported recommendations by US primary care physicians (PCPs) on screening intervals that incorporate HPV ...
متن کاملHuman papillomavirus DNA versus papanicolaou screening tests for cervical cancer.
BACKGROUND To determine whether testing for DNA of oncogenic human papillomaviruses (HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted a randomized trial comparing the two methods. METHODS We compared HPV testing, using an assay approved by the Food and Drug Administration, with conventional Pap testing as a screening method to identify high-grade cer...
متن کاملHuman Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
From the Departments of Oncology and Epidemiology & Biostatistics (M.-H.M., J.H., F.C., E.L.F.), Family Medicine (E.D.-F.), and Pathology (A.F.), McGill University, Montreal; the Départements d’ObstétriqueGynécologie (M.-H.M.) and de Médecine Familiale (I.R.), Université de Montréal, Montreal; the Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON (S.D.W.);...
متن کاملPnm-17: Cost Effectiveness of Human Papillomavirus Testing in Cervical Cancer Diagnosis
Background: Epidemiological studies are shown robust association between human papillomavirus (HPV) and cervical cancer. From 1990 HPV was known as a necessary but insufficient cause of cervical invasive cancer. The purpose of this study was to evaluate the cost effectiveness of HPV test in cervical cancer screening. Materials and Methods: This is a systematic review article; the newest scienti...
متن کاملPractice patterns in cervical cancer screening and human papillomavirus testing.
The use of human papillomavirus DNA testing plus Papanicolaou (Pap) testing (cotesting) for cervical cancer screening in women 30 years and older has been recommended since 2006. However, few studies have detailed the adoption of such cotesting in clinical practice. We examined the trends in monthly percentage of Pap tests ordered as cotests in our laboratory over a 2.5-year period and used joi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Internal Medicine
سال: 2010
ISSN: 0003-9926
DOI: 10.1001/archinternmed.2010.134